Skip to main content
SpringerLink
Log in
Book cover

Endocrine Surgery pp 221–234Cite as

Presentation and Diagnosis of Primary Hyperparathyroidism

  • Chapter
  • First Online:

  • 1766 Accesses

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

The term hyperparathyroidism was first coined in the 1920s to describe a syndrome characterized by bone disease, renal stones, fatigue, hypercalcemia, and hypercalciuria [1]. The diagnosis was dependent on symptoms related to “bones, stones, abdominal groans and moans” which often correlated with osteitis fibrosa cystica, advanced kidney disease, psychiatric, and neuromuscular disorders, respectively.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Organ, C. The history of parathyroid surgery, 1850–1996; the excelsior surgical society 1998 Edward D Churchill lecture. J Am Coll Surg. 2000;191: 284–99.

    Article  PubMed  Google Scholar 

  2. Clark OH, Duh QY. Primary hyperparathyroidism. A surgical perspective. Endocrinol & Metab Clin N Am. 1989;18(3):701–14, 284–99.

    CAS  Google Scholar 

  3. Adami S, Marocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002;17(suppl. 2):N18–23.

    PubMed  Google Scholar 

  4. Melton JL. The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res. 2002;17(suppl. 2):N12–7.

    PubMed  Google Scholar 

  5. Anonymous. Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29–31, 1990. J Bone Miner Res. 1991;6(suppl 2):S1–166.

    Google Scholar 

  6. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and economic impact in a community. N Eng J Med. 1980;302:189.

    Article  Google Scholar 

  7. Lundgren E, Rastad J, Thrufjell E, Åkerström G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery. 1997;121(3):287–94.

    Article  PubMed  CAS  Google Scholar 

  8. Lundgren E, Hagstrom EG, Lundin J, Winnerback K, Roos J, Ljunghall S, Rastad J. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg. 2002;26(8):931–6.

    Article  PubMed  Google Scholar 

  9. Stephen AE, Chen KT, Milas M, Siperstein AE. The coming of age of radiation-induced hyperparathyroidism: evolving patterns of thyroid and parathyroid disease after head and neck irradiation. Surgery. 2004;136(6):1143–53.

    Article  PubMed  Google Scholar 

  10. Hundley JC, Woodrum DT, Saunders BD, Doherty GM, Gauger PG. Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery. 2005;138(6):1027–31.

    Article  PubMed  Google Scholar 

  11. Cetani F, Pardi E, Ambrogini E, Lemmi M, Borsari S, Cianferotti L, Vignali E, Viacava P, Berti P, Mariotti S, Pinchera A, Marcocci C. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. Clin Endocrinol. 2006;64(2):146–52.

    Article  CAS  Google Scholar 

  12. Benson L, Ljunghall S, Åkerström G, Öberg K. Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1 (MEN1). Am J Med. 1987;82:731–737.

    Article  PubMed  CAS  Google Scholar 

  13. Malone JP, Srivastava A, Khardori R. Hyperparathyroidism and multiple endocrine neoplasia. Otolaryngol Clin N Am. 2004;37(4):715–36.

    Article  Google Scholar 

  14. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe – nationwide cohort analysis on mortality from nonmalignant causes. J Bone Min Res 2002;17(Suppl 2):N68–74.

    Google Scholar 

  15. Ljunghall S, Per Hellman P, Rastad J, Åkerström G. Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg. 1991;15(6):681–7.

    Article  PubMed  CAS  Google Scholar 

  16. Jacob JJ, John M, Thomas N, Chacko A, Cherian R, Selvan B, Nair A, Seshadri M. Does hyperparathyroidism cause pancreatitis? A South Indian experience and a review of published work. ANZ J Surg. 2006;76(8):740–4.

    Article  PubMed  Google Scholar 

  17. Carella MJ, Gossain VV. Hyperparathyroidism and pregnancy: case report and review. J Gen Int Med. 1992;7(4):448–53.

    Article  CAS  Google Scholar 

  18. Clark OH, Wilkes W, Siperstein AE, Duh QY. Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge. J Bone Min Res. 1991;6(Suppl 2):S135–42.

    Google Scholar 

  19. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.

    Article  Google Scholar 

  20. Burney RE, Jones KR, Peterson M, Christy B, Thompson NW. Surgical correction of primary hyperparathyroidism improves quality of life. Surgery. 1998;124:987–92.

    Article  PubMed  CAS  Google Scholar 

  21. Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM, Mirallie E. Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 2007;141(2):153–9.

    Article  PubMed  Google Scholar 

  22. Pasieka JL, Parsons LL. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg. 1998;22(6):513–8.

    Article  PubMed  CAS  Google Scholar 

  23. Sadler GP, Mihai R, Jeevan D. Pasieka’s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing parathyroidectomy for primary hyperparathyroidism. International surgical week 2007 Abstract 073.

    Google Scholar 

  24. Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, et al. A patient-based surgical outcome tool demonstrating improvement of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg. 2002;26:942–9.

    Article  PubMed  Google Scholar 

  25. Sywak MS, Knowlton ST, Pasieka JL, Parsons LL, Jones J. Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery. 2002;132(6):1013–9.

    Article  PubMed  Google Scholar 

  26. Grey A, Evans M, Stapleton J, Reid I. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Int Med. 1994;121(10):745–9.

    PubMed  CAS  Google Scholar 

  27. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe – nationwide cohort analysis on mortality from nonmalignant causes. J Bone Min Res. 2002;17(Suppl 2):N68–74.

    Google Scholar 

  28. Lundgren E, Lind L, Palmer M, Jakobsson S, Ljunghall S, Rastad J. Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery. 2001;130(6):978–85.

    Article  PubMed  CAS  Google Scholar 

  29. Hagstrom E, Lundgren E, Mallmin H, Rastad J, Hellman P. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J Int Med. 2006;259(2):191–8.

    Article  CAS  Google Scholar 

  30. Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P, Rastad J. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol. 2002;56(2):253–60.

    Article  Google Scholar 

  31. Valdemarsson S, Lindblom P, Bergenfelz A. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J Int Med. 1998;244(3):241–9.

    Article  CAS  Google Scholar 

  32. Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007;92(5):1687–92.

    Article  PubMed  CAS  Google Scholar 

  33. Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL, Bilezikian JP. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med. 1990;89(3):327–34.

    Article  PubMed  CAS  Google Scholar 

  34. Dauphine RT, Riggs BL, Scholz DA. Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism. Ann Int Med. 1975;83(3):365–7.

    PubMed  CAS  Google Scholar 

  35. Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Heath H 3rd. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Int Med. 1992;152(11):2269–73.

    Article  Google Scholar 

  36. Dempster DW, Muller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP. Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 2007;41(1):19–24.

    Article  PubMed  CAS  Google Scholar 

  37. Parisien M, Cosman F, Mellish RW, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP et al. Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Min Res. 1995;10(9):1393–9.

    Article  CAS  Google Scholar 

  38. VanderWalde LH, Liu IL, O’Connell TX, Haigh PI. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Arch Surg. 2006;141(9):885–9.

    Article  PubMed  Google Scholar 

  39. Gardner EC Jr, Hersh T. Primary hyperparathyroidism and the gastrointestinal tract. Southern Med J. 1981;74(2):197–9.

    Article  Google Scholar 

  40. Mowat E, Gunn A, Paterson CR. Hyperparathyroidism in peptic ulcer patients. BJS. 1981;68(7):455–8

    Article  CAS  Google Scholar 

  41. Gardner EC Jr, Hersh T. Primary hyperparathyroidism and the gastrointestinal tract. Southern Med J. 1981;74(2):197–9.

    Article  Google Scholar 

  42. Bess M, Edis A, Von Heerden J. Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA. 1980;243:246–7.

    Article  PubMed  CAS  Google Scholar 

  43. Shepherd J. Hyperparathyroidism presenting as pancreatitis or complicated by postoperative pancreatitis. Aust NZ J Surg. 1996;66:85–7.

    Article  CAS  Google Scholar 

  44. Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C. Pancreatitis and primary hyperparathyroidism: forty cases. Aust NZ J Surg. 1998;68:117–9.

    Article  CAS  Google Scholar 

  45. Caroll M, Schade D. A practical approach to hypercalcaemia. Am Fam Physician. 2003;67(9):1959–66.

    Google Scholar 

  46. Kebebew E, Clark O. Parathyroid adenoma, hyperplasia, and carcinoma. Surg Oncol Clin North Am. 1998;7:721–48.

    CAS  Google Scholar 

  47. Binstock ML, Mundy GR. Effect of calcitonin and glucocorticoids in combination on the hypercalcaemia of malignancy. Ann Intern Med. 1980;87:269–72.

    Google Scholar 

  48. Lew J, Solorzano C, Irvin G. Long term results of parathyroidectomy for hypercalcaemic crisis. Arch Surg. 2006;141:696–9.

    Article  PubMed  Google Scholar 

  49. Ziegler R. Hypercalcaemic crisis. J Am Soc Nephrol. 2001;12:S3–9.

    PubMed  Google Scholar 

  50. Inabnet W, Lee J, Henry JF, Sebag F. Parathyroid disease. In: Lennard T, ed., A companion to specialist surgical practice: endocrine surgery, 3rd ed. Amsterdam: Elsevier Saunders, 2006;6–8.

    Google Scholar 

  51. Major PP, Coleman RE. Zoledronic acid in the treatment of hypercalcaemia of malignancy: results of the international clinical development program. Semin Oncol 2001;28(2 suppl 7):17–24.

    Article  PubMed  CAS  Google Scholar 

  52. Silva OL, Becker KL. Salmon calcitonin in the treatment of hypercalcaemia. Arch Int Med. 1973;132:337–9.

    Article  CAS  Google Scholar 

  53. Binstock ML, Mundy GR. Effect of calcitonin and glucocorticoids in combination on the hypercalcaemia of malignancy. Ann Int Med. 1980;93:269–72.

    PubMed  CAS  Google Scholar 

  54. Rodriguez A, Trujillo MJ, Herrero T, et al. Allergy to calcitonin. Allergy. 2001;58:801.

    Article  Google Scholar 

  55. Davidson TG. Conventional management of hypercalcaemia of malignancy. Am J Health-System Pharm. 2001;58(suppl 3):S8–15.

    Google Scholar 

  56. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990;112:352–64.

    PubMed  CAS  Google Scholar 

  57. Strumpf M, Kowalski MA, Mundy GR. Effects of glucocorticoids on osteoclas-activating factor. J Lab Clin Med. 1978;92:772–8.

    PubMed  CAS  Google Scholar 

  58. Tisell L, Hedback G, Jansson S, Lindtstedt G, Zachrisson B. Management of hyperparathyroid patients with grave hypercalcaemia. World J of Surg. 1991;15:730–7.

    Article  CAS  Google Scholar 

  59. Lew J, Solorzano C, Irvin G. Long term results of parathyroidectomy for hypercalcaemic crisis. Arch Surg. 2006;141:696–9.

    Article  PubMed  Google Scholar 

  60. Monchik J, Gorgun E. Normocalcaemic hyperparathyroidism in patients with osteoporosis. Surgery. 2004;136:1242–6.

    Article  PubMed  Google Scholar 

  61. Mather HG. Hyperparathyroidism with normal serum calcium. BMJ. 1953;2:424–5.

    Article  PubMed  CAS  Google Scholar 

  62. Maruani G, Hurtig A, Paillard M, Houillier P. Normocalcaemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab. 2003;88:4641–8.

    Article  PubMed  CAS  Google Scholar 

  63. Lowe H, McMahon J, Rubin M, Bilezikian J, Silvergerg S. Normocalcaemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92:3001–5.

    Article  PubMed  CAS  Google Scholar 

  64. Hagstrom E, Lundgren E, Rastad J, Hellman P. Metabolic abnormalities in patients with normocalcaemic hyperparathyroidism detected at a population-based screening. Eur J Endocrinol. 2006;155:33–9.

    Article  PubMed  Google Scholar 

  65. Poole Jr GV, Albertson AD, Myers RT. Normocalcaemic hyperparathyroidism revisited. Am Surg. 1983;49:668–71.

    PubMed  Google Scholar 

  66. Hagag P, Revet-Zak I, Hod N et al. Diagnosis of normocalcaemic hyperparathyroidism by oral calcium loading test. J Endocrinol Invest. 2003;26(4):327–32.

    PubMed  CAS  Google Scholar 

  67. Monchick JM. Normocalcaemic hyperparathyroidism. Surgery. 1995;118(6):917–23.

    Article  Google Scholar 

  68. Payne, M. Albumin-adjusted calcium. Med Lab Obs 2004; 36(5).

    Google Scholar 

  69. Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab. 1986;56:572–81.

    Article  Google Scholar 

  70. Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med. 1995;333:234–40.

    Article  PubMed  CAS  Google Scholar 

  71. Khosla S, Ebelling PR, Firek AF, et al. Calcium infusion suggests a ‘set point’ abnormality of parathyroid gland function in familial benign hypercalcaeima and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab. 1993;76:715–20.

    Article  PubMed  CAS  Google Scholar 

  72. KIfor S, Moore FD Jr, Wang P, et al. Reduced immunostaining for the extracellular Ca+2-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81:1598–606.

    Article  PubMed  CAS  Google Scholar 

  73. Ariyan C, Sosa J. Assessment and management of patients with abnormal calcium. Crit Care Med. 2004;32 suppl:S146–54.

    Article  PubMed  Google Scholar 

  74. Strewler GJ, Budayr AA, Clark OH, Nissenson RA. Production of parathyroid hormone by a malignant nonparathyroid tumor in a hypercalcemic patient. J Clin Endocrinol Metab. 1993;76(5):1373–5.

    Article  PubMed  CAS  Google Scholar 

  75. Attie MF, Gill Jr JR, Stock JL, Spiegel AM, Downs Jr RW, Levine MA, Marx SJ. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest. 1983 August; 72(2): 667–76.

    Article  PubMed  CAS  Google Scholar 

  76. Vieweg J, Teh C, Freed K, Leder RA, Smith RH, Nelson RH, et al. Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain. J Urol. 1998;160(3 Pt 1):679–84.

    PubMed  CAS  Google Scholar 

  77. Sinclair D, Wilson S, Toi A, Greenspan L. The evaluation of suspected renal colic: ultrasound scan versus excretory urography. Ann Emerg Med. 1989;18(5):556–9.

    Article  PubMed  CAS  Google Scholar 

  78. Erwin BC, Carroll BA, Sommer FG. Renal colic: the role of ultrasound in initial evaluation. Radiology. 1984;152(1):147–50.

    PubMed  CAS  Google Scholar 

  79. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843. Geneva: WHO, 1994.

    Google Scholar 

  80. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease. Guidelines for diagnosis and management of osteoporosis. Osteoporosis Int 1997;7:390–406.

    Article  CAS  Google Scholar 

  81. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement 2000; 17(1): 1–36.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrine Surgery, Hammersmith Hospital, London, UK

    Jenny Gough (MBBS, FRACS)

  2. Hammersmith Hospital, London, UK

    F. Fausto Palazzo (MS, FRCS)

Authors
  1. Jenny Gough
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Fausto Palazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom

    Johnathan Hubbard

  2. Coll Physicians & Surgeons Columbia, Fort Washington Avenue 161, New York, 10032, U.S.A.

    William B. Inabnet

  3. Queen Mary Hospital, University of Hong Kong Medical Centre, Pokfulam, Hong Kong, China, People's Republic

    Chung-Yau Lo

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Gough, J., Palazzo, F.F. (2009). Presentation and Diagnosis of Primary Hyperparathyroidism. In: Hubbard, J., Inabnet, W., Lo, CY. (eds) Endocrine Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/978-1-84628-881-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-881-4_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-880-7

  • Online ISBN: 978-1-84628-881-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation